Tigabu Kassa

Array ( [id] => 6755320 [patent_doc_number] => 20030003097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Recombinant antibodies coexpressed with GnTIII' [patent_app_type] => new [patent_app_number] => 10/113929 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23140 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003097.pdf [firstpage_image] =>[orig_patent_app_number] => 10113929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985094 [patent_doc_number] => 20020098187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Vascular endothelial cell growth factor antagonists' [patent_app_type] => new [patent_app_number] => 10/104427 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11728 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098187.pdf [firstpage_image] =>[orig_patent_app_number] => 10104427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869483 [patent_doc_number] => 20030082172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma' [patent_app_type] => new [patent_app_number] => 10/096964 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082172.pdf [firstpage_image] =>[orig_patent_app_number] => 10096964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6673825 [patent_doc_number] => 20030059428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Treatment of autoimmune diseases' [patent_app_type] => new [patent_app_number] => 10/096127 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18878 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059428.pdf [firstpage_image] =>[orig_patent_app_number] => 10096127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405934 [patent_doc_number] => 20020182645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Direct selection of cells by secretion product' [patent_app_type] => new [patent_app_number] => 10/094461 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10460 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182645.pdf [firstpage_image] =>[orig_patent_app_number] => 10094461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530207 [patent_doc_number] => 20020136733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Malaria peptides' [patent_app_type] => new [patent_app_number] => 10/042202 [patent_app_country] => US [patent_app_date] => 2002-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4343 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136733.pdf [firstpage_image] =>[orig_patent_app_number] => 10042202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6438828 [patent_doc_number] => 20020128200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals' [patent_app_type] => new [patent_app_number] => 10/011436 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4654 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128200.pdf [firstpage_image] =>[orig_patent_app_number] => 10011436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921148 [patent_doc_number] => 20020114813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Compounds' [patent_app_type] => new [patent_app_number] => 09/989902 [patent_app_country] => US [patent_app_date] => 2001-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6771 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114813.pdf [firstpage_image] =>[orig_patent_app_number] => 09989902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5845194 [patent_doc_number] => 20020132764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Combinations of immunosupressive agents for the treatment or prevention of graft rejections' [patent_app_type] => new [patent_app_number] => 10/035663 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4943 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132764.pdf [firstpage_image] =>[orig_patent_app_number] => 10035663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4481699 [patent_doc_number] => 07901693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Compositions and methods for WT1 specific immunotherapy' [patent_app_type] => utility [patent_app_number] => 10/002603 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 53 [patent_no_of_words] => 44411 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/901/07901693.pdf [firstpage_image] =>[orig_patent_app_number] => 10002603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441890 [patent_doc_number] => 20020128448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Variant IgG3 Rituxan and therapeutic use thereof' [patent_app_type] => new [patent_app_number] => 09/982849 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14158 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128448.pdf [firstpage_image] =>[orig_patent_app_number] => 09982849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985086 [patent_doc_number] => 20020098182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G' [patent_app_type] => new [patent_app_number] => 09/966119 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5380 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098182.pdf [firstpage_image] =>[orig_patent_app_number] => 09966119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6654176 [patent_doc_number] => 20030077283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Topical treatment of psoriasis using neutralizing antibodies to IL-8' [patent_app_type] => new [patent_app_number] => 09/956968 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6308 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077283.pdf [firstpage_image] =>[orig_patent_app_number] => 09956968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745643 [patent_doc_number] => 20030022826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents' [patent_app_type] => new [patent_app_number] => 09/956940 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10758 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022826.pdf [firstpage_image] =>[orig_patent_app_number] => 09956940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241379 [patent_doc_number] => 20020044942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Transfer factor composition and process for producing same' [patent_app_type] => new [patent_app_number] => 09/954961 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5015 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044942.pdf [firstpage_image] =>[orig_patent_app_number] => 09954961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496318 [patent_doc_number] => 20020025321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Composition for the prevention and/or treatment of atherosclerosis' [patent_app_type] => new [patent_app_number] => 09/944592 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7897 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025321.pdf [firstpage_image] =>[orig_patent_app_number] => 09944592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905033 [patent_doc_number] => 20020141995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Method for treatment of inflammatory disease' [patent_app_type] => new [patent_app_number] => 09/945250 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18266 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20020141995.pdf [firstpage_image] =>[orig_patent_app_number] => 09945250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813217 [patent_doc_number] => 20030072767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Compositions and methods for WT1 specific immunotherapy' [patent_app_type] => new [patent_app_number] => 09/938864 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 42813 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072767.pdf [firstpage_image] =>[orig_patent_app_number] => 09938864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468585 [patent_doc_number] => 20040096445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Subunit vaccines with A2 supermotifs' [patent_app_type] => new [patent_app_number] => 09/935476 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25017 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096445.pdf [firstpage_image] =>[orig_patent_app_number] => 09935476 [rel_patent_id] =>[rel_patent_doc_number] =>)